Diagnostic reference level, achievable dose, and effective dose estimation in adult hybrid SPECT myocardial perfusion imaging in Institut Jantung Negara

国家心脏中心成人混合SPECT心肌灌注显像的诊断参考水平、可实现剂量和有效剂量估算

阅读:1

Abstract

This study aims to establish the diagnostic reference level (DRL), achievable dose (AD), and effective dose (ED) estimation for adult hybrid SPECT myocardial perfusion imaging (MPI) procedures at Institut Jantung Negara (IJN). 737 subjects referred for MPI studies from January to June 2024 were included in the analysis. These subjects underwent either a one-day or two-day Tc-99 m tetrofosmin protocol using a cardiac-dedicated single-photon emission computed tomography (SPECT), either GE SPECT Discovery NM530c or GE SPECT Ventri. All subjects also underwent a cardiac CT scan via an external positron emission tomography/computed tomography (PET/CT) system, GE Discovery MI Digital Ready for either CT attenuation correction (CTAC) or CT coronary artery calcium score (CAC) protocol, depending on their clinical condition. The one-day protocol showed AD of 240.50 MBq and 691.90 MBq for the first and second injections, respectively, with corresponding DRL of 263.63 MBq and 777.93 MBq. The two-day protocol involved higher ADs of 1106.30 MBq and 1073.00 MBq for the first and second injections, with DRL of 1239.50 MBq and 1221.00 MBq, respectively. In the CTAC protocol, the AD for CT dose index volume (CTDI(vol)) was 2.8 mGy, with a DRL of 4.3 mGy. The dose length product (DLP) had an AD of 53.1 mGy.cm, compared to a DRL of 78.6 mGy.cm. For the CAC protocol, the CTDI(vol) had an AD of 4.8 mGy, matching the DRL of 4.8 mGy. The DLP showed an AD of 67.8 mGy.cm, with a DRL of 77.5 mGy.cm. The mean cumulated effective dose (ED(CUMULATED)) for one-day/CTAC, one-day/CAC, two-day/CTAC, and two-day/CAC was 6.69 ± 1.76 mSv, 7.32 ± 1.37 mSv, 10.13 ± 5.31 mSv, and 13.99 ± 3.24 mSv respectively. The average ED relative contribution by SPECT and CT were found to be 78.3% and 21.7% respectively. The DRL, AD, and ED data were successfully established for local MPI practice, contributing to global efforts to harmonize and enhance radiation safety in MPI practices.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。